Past Programs
Biotechnology - 2006
Biotech profile Read Transcript
20/05/2006
The names CSL, Cochlear and Resmed would be reasonable familiar to most of us.
But outside a handful of high profile and commercially successful businesses, Australia's biotechnolgy sector is more often defined in terms of dreams rather than realities.
Of the roughly 140 stocks that could loosely be defined as biotechnology, a large percentage will never navigate the many financial and regulatory hurdles that stand between a good idea and the finished product.
